Irinotecan and Taxotere With Radiotherapy as Preoperative Treatment in Resectable Esophageal Cancer

NCT00318903 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

25

Enrollment

OTHER

Sponsor class

Conditions

Esophageal Cancer
Cancer of the Esophagus
Esophagus Cancer
Esophageal Neoplasm
Cancer of Esophagus

Interventions

DRUG: Irinotecan (drug)
DRUG: Taxotere (drug)
PROCEDURE: Radiotherapy (procedure)
PROCEDURE: Esophagectomy (procedure)

Sponsor

University of Alabama at Birmingham

Collaborators

[object Object]
[object Object]